SANJAY AGGARWAL: Open Payments
NPI 1912927658 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,691 in 58 payments from 14 companies in 2025. Trend: 2023 $1,757 · 2024 $1,800 · 2025 $1,691
Food & beverage: $1,691
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $455 |
| Indivior Inc. | 11 | $294 |
| ABBVIE INC. | 17 | $291 |
| GlaxoSmithKline, LLC. | 4 | $192 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Alkermes, Inc. | 3 | $73 |
| Braeburn Inc. | 3 | $63 |
| Orexo US, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $33 |
Products named: SUBLOCADE, AIRSUPRA, VRAYLAR, BREZTRI, VOQUEZNA, NUCALA, VIVITROL, BRIXADI.
Industry payments across CT — which companies pay providers there.
